Abstract：
OBJECTIVE: The kaupapa of the Caring for Australians and New Zealanders with Kidney Impairment (CARI) Clinical practice guidelines for management of chronic kidney disease for Māori in Aotearoa New Zealand is to provide whānau-centred and evidence-based recommendations to healthcare systems, healthcare providers and healthcare workers. The guidelines include screening, identification, management and system-level responses to chronic kidney disease (CKD) to deliver best practice care to Māori affected by CKD across community, primary and secondary services.
METHODS: The guidelines are funded by the Ministry of Health - Manatū Hauora and are written by a panel of Māori and non-Māori clinicians and literacy experts across Aotearoa New Zealand from Kaupapa Māori organisations, general practice and nephrology units using standardised methods. The guidelines methodology included consultation with whānau Māori with lived experience of CKD and primary and secondary care practitioners. Additional guideline development would be required to inform management of CKD for non-Māori in Aotearoa New Zealand.
RESULTS: The guidelines provide recommendations about equity, governance and accountability, cultural safety, case management, information systems, social determinants of equity and wellbeing and screening.
CONCLUSIONS: Recommendations to health services for Māori with CKD are based on giving effect to Te Tiriti o Waitangi and best practice care to prevent CKD, delaying its progression, treating kidney failure through timely transplantation, delivering in community and providing high-quality symptom management.
METHODS: The guidelines are funded by the Ministry of Health - Manatū Hauora and are written by a panel of Māori and non-Māori clinicians and literacy experts across Aotearoa New Zealand from Kaupapa Māori organisations, general practice and nephrology units using standardised methods. The guidelines methodology included consultation with whānau Māori with lived experience of CKD and primary and secondary care practitioners. Additional guideline development would be required to inform management of CKD for non-Māori in Aotearoa New Zealand.
RESULTS: The guidelines provide recommendations about equity, governance and accountability, cultural safety, case management, information systems, social determinants of equity and wellbeing and screening.
CONCLUSIONS: Recommendations to health services for Māori with CKD are based on giving effect to Te Tiriti o Waitangi and best practice care to prevent CKD, delaying its progression, treating kidney failure through timely transplantation, delivering in community and providing high-quality symptom management.
摘要：
目标：澳大利亚和新西兰人肾脏损害关怀（CARI）的Kaupapa新西兰奥特罗阿毛利人慢性肾脏疾病管理的临床实践指南是为医疗保健系统提供以whānau为中心和基于证据的建议，医疗保健提供者和医护人员。指南包括筛查，identification,对慢性肾脏病（CKD）的管理和系统级响应，为社区中受到CKD影响的毛利人提供最佳实践护理，主要和次要服务。
方法：该指南由卫生部-马纳托·豪拉（ManatóHauora）资助，由毛利人和非毛利人临床医生组成的小组以及来自新西兰奥特罗阿的Kaupapa毛利人组织的扫盲专家撰写，使用标准化方法的一般实践和肾脏科。指导方法包括与whānau毛利人进行咨询，了解CKD的生活经验以及初级和二级保健从业人员。将需要制定其他指南，以告知新西兰奥特罗阿非毛利人的CKD管理。
结果：指南提供了有关股权的建议，治理和问责制，文化安全,案件管理,信息系统,公平和福祉的社会决定因素和筛选。
结论：对患有CKD的毛利人的健康服务的建议是基于对TeTiritioWaitangi的影响和预防CKD的最佳实践护理，延缓其进展,通过及时移植治疗肾衰竭，在社区中提供并提供高质量的症状管理。
方法：该指南由卫生部-马纳托·豪拉（ManatóHauora）资助，由毛利人和非毛利人临床医生组成的小组以及来自新西兰奥特罗阿的Kaupapa毛利人组织的扫盲专家撰写，使用标准化方法的一般实践和肾脏科。指导方法包括与whānau毛利人进行咨询，了解CKD的生活经验以及初级和二级保健从业人员。将需要制定其他指南，以告知新西兰奥特罗阿非毛利人的CKD管理。
结果：指南提供了有关股权的建议，治理和问责制，文化安全,案件管理,信息系统,公平和福祉的社会决定因素和筛选。
结论：对患有CKD的毛利人的健康服务的建议是基于对TeTiritioWaitangi的影响和预防CKD的最佳实践护理，延缓其进展,通过及时移植治疗肾衰竭，在社区中提供并提供高质量的症状管理。
